GleamWall
中文EN

APYX Apyx Medical Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 719135 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY24.4%
TTM net income YoY42.0%
TTM EPS YoY—
Revenue 3-yr CAGR5.8%
Net income 3-yr CAGR—

Margins

Gross margin63.4%
Operating margin-5.5%
Net margin-14.2%
FCF margin-14.9%
EBITDA margin-4.1%

Returns

ROE-109.0%
ROA-14.2%
ROIC (approx.)-14.9%
Asset turnover1.00x

Leverage & solvency

Liabilities / assets83.7%
Debt / equity3.69x
Current ratio4.95x
Interest coverage-0.59x

Cash quality & payout

Operating cash flow / net income0.98x
Accruals ratio-0.4%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$52.84M$48.10M
Cost of revenue$19.80M$18.74M
Gross profit$33.04M$29.36M
R&D expense$3.37M$5.08M
SG&A expense$15.80M$18.86M
Operating income-$6.45M-$18.84M
Interest expense$5.59M$5.91M
Pretax income-$10.84M-$23.31M
Income tax$270,000$252,000
Net income-$11.21M-$23.46M
EBITDA-$5.79M-$18.25M
EPS (basic)-0.27-0.66
EPS (diluted)——
Balance sheet
Cash & equivalents$31.74M$31.74M
Receivables$16.78M$15.48M
Inventory$8.60M$7.56M
Current assets$58.47M$56.44M
PP&E, net$2.37M$1.99M
Total assets$66.84M$64.84M
Current liabilities$11.70M$10.72M
Long-term debt$34.85M$33.89M
Total debt$34.85M$33.89M
Total liabilities$52.01M$50.51M
Shareholders' equity$14.54M$14.21M
Net debt$3.11M$2.15M
Shares outstanding41.79M37.79M
Cash flow statement
Operating cash flow-$8.00M-$18.05M
Capital expenditure$1.11M$722,000
Free cash flow-$9.12M-$18.77M
Investing cash flow-$1.11M-$722,000
Financing cash flow$9.58M$6.75M
Depreciation & amortization$655,000$599,000
Stock-based compensation$2.00M$4.01M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.